ライフサイエンスコーパス: girl

1 [76.1-80.4] of boys and 84.7% [83.0-88.2] of girls).

2 escents (77 707 [47.2%] boys; 86 926 [52.8%] girls).

3 ) and GUSTO from Singapore (n = 312 boys and girls).

4 t and daytime sleepiness score in adolescent girls.

5 ude of divergence in levels between boys and girls.

6 The overall effects were similar in boys and girls.

7 eparate analyses were performed for boys and girls.

8 ity and suicide ideation with planning among girls.

9 rls with TS relative to typically developing girls.

10 t significantly different from estimates for girls.

11 of all participants was 7 years and 55% were girls.

12 nd 51.4% (49.5-53.3) to 75.4% (73.8-76.9) in girls.

13 the prediction of irritability, seen only in girls.

14 ociations with any adolescent outcomes among girls.

15 ction among both unvaccinated and vaccinated girls.

16 h equations, sex equals 0 for boys and 1 for girls.

17 ties driving excessive risk among adolescent girls.

18 ong 11 participants, there were 7 boys and 4 girls.

19 cture, and were done separately for boys and girls.

20 aspects of pubertal development in boys and girls.

21 ental assessments, of which 354 (48.2%) were girls.

22 , birth length, and head circumference among girls.

23 able access to transplantation for women and girls.

24 5 to 16 years, of whom 141 were boys and 111 girls.

25 ite matter associations were present only in girls.

26 might advance timing of puberty in boys and girls.

27 oys, with connectivity changes restricted to girls.

28 years post-KT was observed in both boys and girls.

29 of human papillomavirus (HPV) vaccination in girls.

30 ively) at 3 and 18 months of age (pooled) in girls.

31 14 deaths, and 306 DALYs per 1000 vaccinated girls.

32 atics scores of high-school boys relative to girls.

33 in comparison with vaccination of 9-year-old girls.

34 icularly (but not exclusively) in adolescent girls.

35 9), respectively, compared with unvaccinated girls.

36 ls and no significant correlation in control girls.

37 , 95% confidence interval (CI) 0.24 to 0.38, girls: 0.18 L, 95% CI 0.12 to 0.25), FVC (boys: 0.36 L,

38 (25-75%) (boys: 0.35 L, 95% CI 0.21 to 0.49, girls: 0.22 L, 95% CI 0.09 to 0.34) adjusted for age, so

39 25), FVC (boys: 0.36 L, 95% CI 0.27 to 0.44, girls: 0.22 L, 95% CI 0.15 to 0.28) and FEF(25-75%) (boy

40 /L (95% CI: 0.02, 0.16 mmol/L) in boys only (girls: -0.00; 95% CI: -0.07, 0.07 mmol/L) and heart rate

41 , 95% CI: - 3.8, 0.3, respectively; beta for girls = 1.8, 95% CI: 0.1, 3.4 and 1.6, 95% CI: 0.0, 3.2,

42 boy)) that a birth yields a boy instead of a girl [1-6], suggesting a potential variation of P(boy) a

43 ue receiving conventional therapy and 29 (16 girls, 13 boys) to receive burosumab.

44 Of these, 32 (18 girls, 14 boys) were randomly assigned to continue recei

45 was associated with higher HIV prevalence in girls 15-19 years old in rural areas and with lower educ

46 -worn GT3X+ actigraph in 160 adolescents (96 girls, 17.7 +/- 0.3 years) followed by assessment of wor

47 ncluding 744 vaccinated and 294 unvaccinated girls (1993-1994) who provide a vaginal self-swab sample

48 l age (6-11 years), from 440 children (49.3% girls, 24.8% born by cesarean delivery; all children exc

49 55 girls with TS and 53 typically developing girls (258 magnetic resonance imaging datasets) spanning

50 range {IQR}] age, 3.1 [2.1-4.2] years; 48.5% girls), 280 (0.31%; 95% CI, 0.27-0.35) had presymptomati

51 ears [interquartile range {IQR}, 5.7-14]; 20 girls [34%]) were identified who met the criteria for PI

52 o were enrolled (median age, 12.4 years; 38% girls), 370 (35%) chose nonoperative management and 698

53 At 120 months, data from 35 2D girls, 38 3D girls, and 30 3D women were used for analys

54 17% increase for teenage motherhood of black girls (40% for whites).

55 omized participants (mean age, 9.8 years; 77 girls [40%]), 180 (93.8%) completed the trial.

56 The study group consisted of 1148 girls (47.2%) and 1286 boys (52.8%) from 2 weeks to 41 m

57 the 5-year follow-up (mean age: 60.0 months; girls: 50.3%; mean wealth index: 45.5 out of 100; breast

58 total of 181 eyes of 92 healthy children (39 girls, 53 boys) aged 6.5 and serving as a term-born cont

59 odine intake, with a higher prevalence among girls (54.6%) compared with boys (40.2%) (P < 0.001).

60 Of 1,536 children (mean age = 9.3 years; 872 girls; 664 boys), 7% were overfat, 13.2% overweight, and

61 33.9 months +/- 1.8 [standard deviation]; 59 girls, 69 boys) were evaluated.

62 boys (72.1%, 71.1-73.6), and south Asia for girls (77.5%, 72.8-89.3).

63 P < 0.001) but slightly less accurate among girls (89.0% vs. 92.6%; P = 0.002).

64 mon among unvaccinated girls than vaccinated girls (9.2% vs. 3.7%).

65 0, 64, and 137 months, respectively) and 156 girls (95 with ASD) scanned at up to three time points (

66 Pacific for both boys (89.0%, 62.8-92.2) and girls (95.6%, 73.7-97.9).

67 predicted a high GHQ12 score at wave 2 among girls (adjusted odds ratio [OR] 1.31 [95% CI 1.06-1.63],

68 A young girl affected by severe type I hyperoxaluria received St

69 biosynthesis in the prenatal virilization of girls affected by congenital adrenal hyperplasia due to

70 first year of life and become more common in girls after the first year of life.

71 e 5-year antibody persistence of the bHPV in girls (age, 9-10 years) and women (age, 18-24 years).

72 We included girls aged <= 11 years referred to our clinic between Ma

73 vaccination at age 9 years with catch-up for girls aged 10-14 years; girls-only vaccination plus once

74 omavirus (HPV) vaccination in 2010 involving girls aged 12 to 18 years and achieving nearly 90% cover

75 creening for anxiety in women and adolescent girls aged 13 years or older who are not currently diagn

76 commendation applies to women and adolescent girls aged 13 years or older who are not currently diagn

77 tly by 54% (RR 0.46, 95% CI 0.33-0.66) among girls aged 13-19 years.

78 of 2358 AGYW), 5.7% (4.1-7.2) in adolescent girls aged 15-19 years (64 of 1156), and 16.7% (14.4-19.

79 tly by 67% (RR 0.33, 95% CI 0.24-0.46) among girls aged 15-19 years, decreased significantly by 54% (

80 across age groups-most notably in women and girls aged 16-24 years, in whom prevalence increased fro

81 Girls aged 9-13 years were randomized to receive 2D or 3

82 oses of AS04-adjuvanted HPV-16/18 vaccine in girls aged 9-14 years or following 3 doses in women aged

83 A total of 535 adolescent girls aged between 12 and 18 years old were recruited fr

84 0 minutes of the first session of VR play, 2 girls (aged 5 and 6 years) and 1 boy (aged 7 years).

85 ldren (390,290 [50.9%] boys; 375,954 [49.1%] girls) aged 4 to 19 years (mean = 10.9) attending Scotti

86 ance imaging (fMRI) data from 68 school-aged girls, along with social network information from all pu

87 y increase in these hospital records in both girls and (HPV-unvaccinated) boys, with no relationship

88 pulation consisted of 314,017 HPV-vaccinated girls and 314,017 age-matched HPV-unvaccinated girls (co

89 al representation by sex in the surveys (52% girls and 48% boys).

90 ng refraction < 3 D in both eyes: 88 (48.9%) girls and 92 (51.1%) boys.

91 ntified urinary RNase 7 concentrations in 29 girls and adolescents with a UTI history and 29 healthy

92 Studies that enrolled adolescent girls and adult women not currently diagnosed with anxie

93 nefits and harms of treatments in adolescent girls and adult women.

94 re even though they are common in adolescent girls and adult women.

95 pital records (SCCS analyses); and 1,465,049 girls and boys (population time trend analyses).

96 001) lower chances of overweight/obesity for girls and boys, respectively.

97 The effect is fairly uniform across girls and boys, socio-economic backgrounds, and location

98 n PM and control boys while negatively in PM girls and no significant correlation in control girls.

99 e home visits to identify pregnant women and girls and provide antenatal and postnatal care.

100 produced more speech-like vocalizations than girls and that the effect size was more than four times

101 ding proficiency levels of 15-y-old boys and girls and the social attitudes toward girls attending un

102 We included 341 girls and their mothers from an ongoing cohort of low-in

103 ons between drought and IPV among adolescent girls and unemployed women.

104 arger positive associations among adolescent girls and unemployed women.

105 child myopia, with increased probability for girls and unexpected reduced probability for boys, possi

106 Among Swedish girls and women 10 to 30 years old, quadrivalent HPV vac

107 used disproportionate illness among pregnant girls and women and HIV-infected persons.

108 During the study period, we evaluated girls and women for cervical cancer until their 31st bir

109 icies that have the potential to ensure that girls and women have equitable access to transplantation

110 Girls and women need effective, safe, and affordable men

111 rs to follow an open population of 1,672,983 girls and women who were 10 to 30 years of age from 2006

112 programmes on HPV infections and CIN2+ among girls and women, and on anogenital warts diagnoses among

113 The cohort comprised 1 076 945 girls and women, of whom 485 408 were vaccinated.

114 form to efficiently reach at-risk adolescent girls and young women (AGYW) for PrEP in HIV high-burden

115 ciency virus (HIV) epidemic among adolescent girls and young women (AGYW) in sub-Saharan Africa is a

116 k Sub-Saharan African population: adolescent girls and young women (AGYW), particularly those under 1

117 mg) among pregnant and postpartum adolescent girls and young women (AGYW).

118 IV acquisition remains high among adolescent girls and young women (AGYW, aged 15-24 years) in sub-Sa

119 te to higher graft failure risks observed in girls and young women compared with boys and young men.

120 Since 2005, HIV incidence among adolescent girls and young women declined in Rakai (Uganda) and Man

121 for fertility preservation interventions in girls and young women newly diagnosed with cancer.

122 estimates of HIV incidence among adolescent girls and young women since ART and before large investm

123 ch as HIV-serodiscordant couples, adolescent girls and young women, female sex workers, and men who h

124 n immunodeficiency virus (HIV) in adolescent girls and young women.

125 rder (MDD) (age mean [SD] = 14.9 +/- 1.5, 56 girls) and 47 healthy controls [14.3 +/- 1.4, 26 girls])

126 cohorts-MAVAN from Canada (n = 139 boys and girls) and GUSTO from Singapore (n = 312 boys and girls)

127 d (PFNA), and perfluorodecanoic acid (PDFA) (girls) and PFHxS and PFHpS (boys) was associated with lo

128 1) a 9-Year-Old Boy, 2) an 11-Year-Old Girl, and 3) an 8-Year-Old Boy.

129 At 120 months, data from 35 2D girls, 38 3D girls, and 30 3D women were used for analyses.

130 Of 1,609 children enrolled, 54.7% were girls, and median age was 11.3 months (interquartile ran

131 12 deaths, and 243 DALYs per 1000 vaccinated girls, and the nonavalent HPV vaccine was estimated to a

132 cy for vaccinated girls, HE for unvaccinated girls, and the protective effectiveness (PE) for all gir

133 tion, as well as the default mode network in girls, and with weaker connectivity to these brain regio

134 clude vaccination of adult women, adolescent girls, and/or young children (both sexes).

135 onsider (i) PrEP availability for adolescent-girls-and-young-women (aged 15-24; AGYW) and female sex

136 However, many affected girls are born virilized, despite low circulating androg

137 Our results indicate that girls are underrepresented in parents' digital narrative

138 antibody concentration was similar in young girls as compared to women.

139 including entrapment and sex-trafficking of girls as fighter brides(17); threats against public figu

140 ed, and concurrently wasted and stunted than girls, as well as being more susceptible to seasonally d

141 nt vaccination of 9-year-old and 12-year-old girls at 90% coverage during 2020-29 in 177 countries.

142 nal samples from vaccinated and unvaccinated girls at age 18.5 years were typed for HPV6/11/16/18/31/

143 emia, boys being more physically active than girls at all ages.

144 e age in identifying the onset of puberty in girls at the Clinica Las Americas in Medellin, Colombia.

145 tion of the stereotype that "math is not for girls" at the country level.

146 ys and girls and the social attitudes toward girls attending university can predict the enrollment in

147 olyangiitis granulomatosis (EGPA) in a young girl being treated for both atopic dermatitis, diagnosed

148 32, -0.02) and a slower height trajectory in girls (beta = -0.30, 95% CI: -0.52,-0.09; P for interact

149 .0; 95% CI: 0.4, 1.6; n = 252) compared with girls (betaMBP = 0.1; 95% CI: - 0.6, 0.7; n = 258) and a

150 ger in female neonates but only persisted in girls between fasting glucose, and sSAT and dSAT at 4.5

151 .1% (1.6-2.7) to 6.8% (6.0-7.8) in women and girls, between 2000 and 2014.

152 from an ongoing cohort of low-income Chilean girls born from 2002-2003.

153 n this population, peaking at approximately (girls-boys) 12-18% at 10-12 months (wasted) and 37-39% a

154 ere similar to those in typically developing girls, but growth trajectories of GM and white matter we

155 uggest that high HPV vaccination coverage of girls can lead to cervical cancer elimination in most LM

156 In total, 104 (10.04 +/- 1.15 years old; 43 girls) children were included in this cross-sectional st

157 rls and 314,017 age-matched HPV-unvaccinated girls (cohort analyses); 11,817 girls with hospital reco

158 In boys and girls (combined), PFNA and PFDA were associated with BF%

159 gdala and putamen (beta = 0.475, p=0.007) in girls compared to boys.

160 The age at which girls develop breasts is decreasing, which raises the ri

161 ability and autism-like symptoms that affect girls during early childhood.

162 They are equally common in boys and girls during the first year of life and become more comm

163 ovements in health service access, women and girls' education, improved agricultural production, and

164 iciency and negative social attitudes toward girls' education, which suppresses college enrollment in

165 on strategies; and a commitment to improving girls' education.

166 ncrease in DALYs averted per 1000 vaccinated girls for both the bivalent or quadrivalent and nonavale

167 by WHO region and was higher among boys than girls for injuries (47.8% vs 37.5%, p=0.00094), physical

168 of 20 513 of 40 852 of 39 420 resident boys/girls from 1992 to 1995 birth cohorts consented.

169 This study was restricted to unvaccinated girls from the pre-vaccination cohort (n=5245) and vacci

170 e-vaccination cohort (n=5245) and vaccinated girls from the vaccine-eligible cohort (n=4904).

171 ied concurrent HPV infections in 17-year-old girls from two birth cohorts; the first vaccine-eligible

172 n 2001), there was no significant change for girls (from 85.1% [83.1-88.0] in 2001).

173 A total of 28.8% of boys and 28.1% of girls had overweight/obesity, and 7.5% of boys and 17.5%

174 We examined whether girls have nonspecific outcomes of HPV vaccination, usin

175 Vaccine efficacy for vaccinated girls, HE for unvaccinated girls, and the protective eff

176 hich interventions could improve women's and girls' health and well-being.

177 control boys (hyper/hypo: 0/2) and 2 control girls (hyper/hypo: 1/1) met the same criteria in only 1

178 Sixteen PM boys (hyper/hypo: 7/9) and 10 PM girls (hyper/hypo: 2/5, 3 both) displayed aberrant LGI i

179 this framing intervention reduces boys' and girls' implicit positive associations with junk food mar

180 fe-years (DALYs) averted per 1000 vaccinated girls in comparison with the counterfactual scenario of

181 Adolescent girls in humanitarian settings are especially vulnerable

182 illomavirus (HPV) vaccination for adolescent girls in India.

183 y secondary sexual characteristic in boys or girls in relation to T2D/IGT.

184 development using data from 15,822 boys and girls in the longitudinal Puberty Cohort, nested within

185 imary analysis (median age, 1.8 years; 47.3% girls), in which there were 728 patients randomized to t

186 of ADHD in association with PFAS exposure in girls, in children from nulliparous women, and in childr

187 In contrast, girls included by WLZ-O had 0.17 (95% CI 0.01; 0.33) kg/

188 ng puberty have stronger proximal effects on girls, including an increased risk of developing mood-re

189 For girls initiating vaccination at age 12-14 years and 15-1

190 ntributed to negative impacts on women's and girls' lives.

191 A 5-year-old girl living in Koriyama, Fukushima Prefecture was admitt

192 Among girls, maternal and paternal WC mediated 20% and 14% of

193 p = 0.048), with the effect being greater in girls (MD = -0.18, -0.32 to -0.05, p = 0.007, p for inte

194 A total of 232 adolescent girls (mean age 15.29 +/- 0.65 years) were assessed with

195 A sample of children (n = 129, 75 girls, mean 10.6 years of age), approximately half of wh

196 al of 47 cases were included (28 boys and 19 girls; mean age, 31 days).

197 ) or suspected of having JIA (seven boys, 38 girls; median age, 14 years [interquartile range, 12-16

198 Attention to women's and girls' menstrual needs is critical for global health and

199 related to very frequent social media use in girls might be due to a combination of exposure to cyber

200 critical body weight for pubertal timing in girls, most studies have focused on BMI and reported an

201 cenario of no vaccination, and the number of girls needed to be vaccinated to prevent a single case,

202 ted with suicidal ideation with planning for girls (odds ratio (OR) 1.12, 95% CI 1.02 to 1.22, p = 0.

203 ntly increased the probability of myopia for girls (odds ratio [OR] = 1.07; 95% confidence interval [

204 hin clusters were all ever-married women and girls of reproductive age (ie, aged 15-49 years) who bec

205 ple consisted of 112 infants (54 boys and 58 girls), of whom 81 were at familial risk for ASD and 31

206 Women and girls older than 15 years seeking maternal and child hea

207 aves 1 and 2 predicted lower wellbeing among girls only (adjusted ORs 0.86 [0.74-0.99], N=3753, p=0.0

208 reduced by 3.4 bpm (95% CI: 0.2, 6.6 bpm) in girls only (boys: 0.6; 95% CI: -2.6, 3.8 bpm).

209 al arm and 150% and 40% stronger than in the girls-only arm.

210 Girls-only HPV vaccination was predicted to reduce the m

211 es into gender-neutral HPV16/18 vaccination, girls-only HPV16/18 vaccination, and hepatitis B virus v

212 base-case scenarios: girls-only vaccination; girls-only vaccination and once-lifetime screening; and

213 vaccination and once-lifetime screening; and girls-only vaccination and twice-lifetime screening.

214 Cs) were estimated for three core scenarios: girls-only vaccination at age 9 years with catch-up for

215 rs with catch-up for girls aged 10-14 years; girls-only vaccination plus once-lifetime screening and

216 screening and cancer treatment scale-up; and girls-only vaccination plus twice-lifetime screening and

217 Girls-only vaccination was predicted to result in elimin

218 can achieve cervical cancer elimination with girls-only vaccination, elimination could occur between

219 for three standardised base-case scenarios: girls-only vaccination; girls-only vaccination and once-

220 l mean scores were apparent between boys and girls or between poverty threshold classes.

221 1,091) in boys and 27,014 (16,739-65,709) in girls; over 85 years old, NNT was 262 (236-293) in men a

222 g both unvaccinated (p=0.002) and vaccinated girls (p<0.001).

223 s) and 47 healthy controls [14.3 +/- 1.4, 26 girls]) participated in this study.

224 dual energy X-ray absorptiometry, DXA) among girls (percentage of estimates that were <20% of measure

225 Nonmonotonic associations in girls (PFOS, PFHpS, PFDA) and boys (PFDA, PFNA) were obs

226 ned puberty indicator in the middle tertile [girls: PFOS: [Formula: see text] mo, 95% confidence inte

227 Inclusion of girls' prepubertal body mass index slightly attenuated t

228 A 10-year-old girl presented with ileus, urinary retention, dry mouth,

229 By 2072, when the first vaccinated cohort of girls reaches 70 years of age, vaccination yielded a 22.

230 POI is particularly devastating for young girls reaching puberty, because it irreversibly affects

231 sociated with subsequent diffuse symptoms in girls, reducing public confidence in the vaccine.

232 th age at a slower rate in autistic boys and girls relative to typically developing control subjects.

233 The girls reported discomfort consistent with mild motion si

234 eight/obesity, and 7.5% of boys and 17.5% of girls reported suicidal ideation with planning over the

235 olds for problem behaviors; and (4) boys and girls require different responses for misbehavior.

236 Bivalent HPV vaccination of 12-year-old girls resulted in a 3.9% reduction in incident cases fro

237 ar for RFM and BMI-for-age percentiles among girls (RFM: 8.0%; BMI-for-age: 6.6%; P = 0.076) and boys

238 love and the sheltered environment of my all-girls school and college experiences, which nurtured my

239 a case of a unilateral HOD in a 16-year-old girl several months after a subtotal excision of a brain

240 ed with 6062 eligible children (3115 [51.4%] girls [sex unknown in seven], median age 8 years [IQR 5-

241 Further reduction in anemia in school girls should focus on correcting iron deficiency.

242 engage in play more often than girls whereas girls start foraging wild plants from early childhood an

243 ), happiness (47.7%), and anxiety (32.4%) in girls, such that these associations (except for anxiety)

244 A 2-dose schedule is highly immunogenic in girls, suggesting a high immune memory.

245 nk relative to their parents, and poor black girls' teenage motherhood.

246 80% of a standard deviation (SD) larger for girls than boys, a magnitude considered as very large.

247 with these effects being more pronounced in girls than in boys.

248 HPV types was more common among unvaccinated girls than vaccinated girls (9.2% vs. 3.7%).

249 For girls, the adjusted probability of violence outcomes was

250 alth impact of HPV vaccination of 9-year-old girls, the combined updates to demography, disability we

251 nd types of problematic behavior in boys and girls, there has been little research examining the ecoc

252 ts as measured by the SRS-2 in boys, but not girls; these small size effects were mitigated by first

253 We analysed EC gene expression data from boy-girl twins at birth and in non-twin adults to detect sex

254 t dialysis initiation were more often white, girls, underweight or obese, and more likely to have GN

255 Thirty-eight full-term infants (20 boys, 18 girls) underwent MRI examination at 2 weeks of age (14.3

256 d with substantial protection against GWs in girls vaccinated at age <=16 years.

257 Girls vaccinated with a 2-dose schedule of bHPV or qHPV

258 cortisol to higher internalizing symptoms in girls via alterations in neonatal amygdala connectivity

259 HistoryA 13-year-old girl was born to consanguineous parents.

260 A 6-year-old girl was referred to our hospital because of repetitive

261 life stress in community-dwelling adolescent girls was associated with altered frontal/parietal corti

262 y of the 2-dose versus 3-dose schedule among girls was evaluated at months 54 (n = 639) and 64 (n = 9

263 The recipient, a 3-year-old girl weighing 14 kg at the time of transplantation, suff

264 FMI models for girls were created for each race/ethnicity.

265 Surprisingly, boys and girls were equally likely to has resolved asthma (33% vs

266 ealth benefits of vaccination of 12-year-old girls were estimated to be similar but slightly decrease

267 nd the protective effectiveness (PE) for all girls were estimated.

268 GMT ratios (cLIA) for both 2D and 3D girls were noninferior to 3 doses in women for HPV6/11/1

269 for HPV6/11/16/18 after 2D or 3D of 4vHPV in girls were noninferior to 3D in adult women up to 120 mo

270 Girls were significantly shorter than boys, but catch-up

271 Girls were vaccinated at age 9 years (with a catch-up to

272 A total of 148 patients (85 boys and 63 girls) were included.

273 hildhood boys engage in play more often than girls whereas girls start foraging wild plants from earl

274 ssociated with increased aneuploidy in young girls, whereas centromeric and more extensive cohesion l

275 of insufficient activity of 90% or more for girls, whereas this was the case for two countries for b

276 Parents tend to prefer boys over girls, which is manifested in reproductive behavior, mar

277 The second is a girl who is compound heterozygous for this haplotype and

278 a shift towards earlier onset of puberty in girls who are obese; however, the situation is less clea

279 A 7-year-old girl with a history of bilateral retinoblastoma (group D

280 obtained without sedation in a six-month-old girl with bilateral multilayered retinal hemorrhages due

281 ate this technique, we present a 13-year-old girl with macula-off exudative retinal detachment second

282 e present here a case study of a 13-year-old girl with severe asthma who switched from omalizumab to

283 ssue (SAT) of weight-stable obese adolescent girls with a similar level of obesity but discordant VAT

284 In girls with ASD, cerebral volumes were similar to those i

285 More than half of boys and two thirds of girls with baseline FEV(1)/FVC ratios of 90% or greater

286 , interventions aiming at normalizing BMI in girls with high values may be warranted to help prevent

287 unvaccinated girls (cohort analyses); 11,817 girls with hospital records (SCCS analyses); and 1,465,0

288 inal and gluteal depots, compared with obese girls with the favorable phenotype.

289 Girls with the unfavorable (high VAT/[VAT + SAT]) phenot

290 -term cognitive behavioral outcomes in young girls with this common genetic condition.

291 We described brain growth trajectories in 55 girls with TS and 53 typically developing girls (258 mag

292 Results show that girls with TS have the following: (1) smaller volume of

293 The parieto-occipital finding suggests that girls with TS may be particularly vulnerable to altered

294 wer growth during typical pubertal timing in girls with TS relative to typically developing girls.

295 Specifically, girls with Turner syndrome have smaller early visual are

296 Human papillomavirus (HPV) vaccination of girls with very high (>90%) coverage has the potential t

297 no increased risk among HPV vaccine-exposed girls, with incidence rate ratios close to 1.0 for abdom

298 Future efforts should aim to increase girls', women's and healthcare professionals' education

299 men, and on anogenital warts diagnoses among girls, women, boys, and men.

300 accination against both diseases, adolescent girls, would be overlapping in Sub-Saharan Africa.